Pfizer reports results from Phase 3 study of Torisel (temsirolimus)
10 August 2012 | By Pfizer
Pfizer Inc. announced the Phase 3 INTORACT trial (B1771006) did not meet its primary endpoint...
List view / Grid view
10 August 2012 | By Pfizer
Pfizer Inc. announced the Phase 3 INTORACT trial (B1771006) did not meet its primary endpoint...
10 August 2012 | By Roche
Phase III study met its co-primary endpoint...
9 August 2012 | By Phenomenex Inc
Phenomenex introduces two new Tabless Tube Holder accessories...
9 August 2012 | By AstraZeneca
AstraZeneca has made an initial payment of approximately $3.2 billion to Amylin Pharmaceuticals...
9 August 2012 | By Novo Nordisk
Sales grew 17% driven by Victoza®, NovoRapid® and Levemir®...
9 August 2012 | By Pfizer
Nodality, Inc.has announced a strategic collaboration with Pfizer Inc..
8 August 2012 | By H. Lundbeck A/S
H. Lundbeck A/S reports first half revenue of DKK 6,829 million...
8 August 2012 | By Teva Pharmaceutical Industries Ltd
The clinical trial protocol has been granted a Special Protocol Assessment agreement...
8 August 2012 | By Pfizer
Company reaches five-year public goal a year earlier than anticipated...
8 August 2012 | By Amgen
Amgen announced a decision to stop the ganitumab Phase 3 GAMMA trial...
8 August 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced the successful completion of the tender offer...
7 August 2012 | By Pfizer
U.S. agencies praise company’s cooperation and compliance program...
7 August 2012 | By GlaxoSmithKline
The European Commission has granted pazopanib marketing authorisation...
7 August 2012 | By Eli Lilly and Company
Eli Lilly and Company announced data from a Phase III trial...
7 August 2012 | By Abbott
The U.S. FDA has approved the Omnilink Elite® Vascular Balloon-Expandable Stent System...